EP2870130A4 - Zusammensetzungen und verfahren zur behandlung von mässigen bis schweren schmerzen - Google Patents

Zusammensetzungen und verfahren zur behandlung von mässigen bis schweren schmerzen

Info

Publication number
EP2870130A4
EP2870130A4 EP13813543.9A EP13813543A EP2870130A4 EP 2870130 A4 EP2870130 A4 EP 2870130A4 EP 13813543 A EP13813543 A EP 13813543A EP 2870130 A4 EP2870130 A4 EP 2870130A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
acute pain
treating moderate
moderate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13813543.9A
Other languages
English (en)
French (fr)
Other versions
EP2870130A2 (de
Inventor
Mahesh Kandula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellix Bio Pvt Ltd
Original Assignee
Cellix Bio Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Pvt Ltd filed Critical Cellix Bio Pvt Ltd
Publication of EP2870130A2 publication Critical patent/EP2870130A2/de
Publication of EP2870130A4 publication Critical patent/EP2870130A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
EP13813543.9A 2012-07-03 2013-06-23 Zusammensetzungen und verfahren zur behandlung von mässigen bis schweren schmerzen Withdrawn EP2870130A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2682CH2012 2012-07-03
PCT/IB2013/055146 WO2014006529A2 (en) 2012-07-03 2013-06-23 Compositions and methods for the treatment of moderate to severe pain

Publications (2)

Publication Number Publication Date
EP2870130A2 EP2870130A2 (de) 2015-05-13
EP2870130A4 true EP2870130A4 (de) 2015-12-02

Family

ID=54188020

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13813543.9A Withdrawn EP2870130A4 (de) 2012-07-03 2013-06-23 Zusammensetzungen und verfahren zur behandlung von mässigen bis schweren schmerzen

Country Status (8)

Country Link
EP (1) EP2870130A4 (de)
JP (1) JP2015527309A (de)
CN (1) CN104583162A (de)
AU (1) AU2013285126A1 (de)
CA (1) CA2873018A1 (de)
SG (1) SG11201407328TA (de)
WO (1) WO2014006529A2 (de)
ZA (1) ZA201408057B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2873094A1 (en) * 2012-05-07 2013-11-14 Cellixbio Private Limited Prodrugs of anti-platelet agents
WO2016046674A1 (en) * 2014-09-28 2016-03-31 Mohan M Alapati Compositions and methods for the treatment of moderate to severe pain
CN105037241B (zh) * 2015-06-19 2018-02-23 上海上药新亚药业有限公司 1‑(2,6‑二氯苯基)‑2‑吲哚酮的合成工艺
CN111116391A (zh) * 2019-12-17 2020-05-08 浙江工业大学 一种2-[(2,6-二氯苯基)氨基]苯乙酸钠的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132318A (en) * 1966-03-30 1968-10-30 Geigy Ag J R New substituted phenylacetic esters, their production and compositions containing them
GB1582420A (en) * 1977-05-11 1981-01-07 Ciba Geigy Ag Phenylamino phenylacetic acid amide compounds and processes for their preparation
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac
WO2009037707A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514991B2 (en) * 1976-05-26 1981-03-12 Commonwealth Of Australia, The Pharmaceutical compositions containing antiinflammatory analgesic compounds
JPS5412340A (en) * 1977-06-27 1979-01-30 Daito Koeki Process for preparing phenylacetate derivative
NL8602767A (nl) * 1986-10-31 1988-05-16 Gantax Nv Organisch zuuranhydride, alsmede farmaceutisch preparaat op basis van een prodrug.
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH1143467A (ja) * 1997-05-14 1999-02-16 Ikeda Mohandou:Kk 脂肪酸グリセライド誘導体及びグリセライド誘導体、並びにそれらの製造方法
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
CN101186583B (zh) * 2007-12-20 2011-05-11 吉林大学 2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
BRPI0901298A2 (pt) * 2009-04-06 2011-01-04 Ems Sa derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
US9525998B2 (en) * 2012-01-06 2016-12-20 Qualcomm Incorporated Wireless display with multiscreen service
CN104081709B (zh) * 2012-01-27 2017-09-08 交互数字专利控股公司 用于在基于多载波和/或准校准网络中提供ePDCCH的装置和/或方法
CA2873094A1 (en) * 2012-05-07 2013-11-14 Cellixbio Private Limited Prodrugs of anti-platelet agents
WO2013167985A1 (en) * 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological disorders
AU2013257707A1 (en) * 2012-05-08 2014-11-27 Cellixbio Private Limited Compositions and methods for the treatment of epilepsy
EP2847161A4 (de) * 2012-05-08 2015-12-23 Cellix Bio Private Ltd Zusammensetzungen und verfahren zur behandlung von diabetes
JP2015533114A (ja) * 2012-05-08 2015-11-19 セリックスビオ プライヴェート リミテッド 神経疾患の治療のための組成物及び方法
EP2847175A4 (de) * 2012-05-08 2016-04-20 Cellix Bio Private Ltd Zusammensetzungen und verfahren zur unterdrückung von carboanhydraseaktivität

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132318A (en) * 1966-03-30 1968-10-30 Geigy Ag J R New substituted phenylacetic esters, their production and compositions containing them
GB1582420A (en) * 1977-05-11 1981-01-07 Ciba Geigy Ag Phenylamino phenylacetic acid amide compounds and processes for their preparation
WO2009037707A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac

Also Published As

Publication number Publication date
CN104583162A (zh) 2015-04-29
SG11201407328TA (en) 2014-12-30
WO2014006529A3 (en) 2014-04-24
AU2013285126A1 (en) 2014-11-27
CA2873018A1 (en) 2014-01-09
JP2015527309A (ja) 2015-09-17
ZA201408057B (en) 2016-03-30
EP2870130A2 (de) 2015-05-13
WO2014006529A2 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
FR24C1025I2 (fr) Compositions et méthodes de traitement de l'anémie
EP2968245A4 (de) Zusammensetzungen und verfahren zur behandlung nichtalkoholischer steatohepatitis
EP2892546A4 (de) Zusammensetzungen und verfahren zur behandlung von hautnarbenbildung
EP3035910A4 (de) Zusammensetzungen und verfahren zur behandlung von haar
EP2819703A4 (de) Schmerzbehandlung
EP2890720A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP2635282A4 (de) Zusammensetzungen und verfahren zur behandlung von myelofibrose
EP2847152A4 (de) Zusammensetzungen und verfahren zur behandlung des stoffwechselsyndroms
EP2932930A4 (de) Behandlungsinstrument
EP2984166A4 (de) Zusammensetzungen und verfahren zur behandlung von mpsi
EP2861263A4 (de) Zusammensetzungen und verfahren zur diabetesbehandlung
EP2723384A4 (de) Behandlung von proteinopathien
EP2892525A4 (de) Verfahren zur behandlung von muskeldystrophien
EP2670434A4 (de) Behandlung von tauopathien
EP2911682A4 (de) Verfahren zur behandlung von anämie
EP2846809A4 (de) Behandlung von myelosuppression
EP2854769A4 (de) Verfahren zur behandlung von arthritis
EP2922591A4 (de) Behandlung von thalamokortikaler dysrhythmie
EP2906208A4 (de) Therapeutische behandlung
EP2854839A4 (de) Verfahren zur behandlung von zöliakie
EP2867378A4 (de) Verarbeitung von biomasse
EP2948135A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen mit pervasiver entwicklung
EP2921510A4 (de) Oberflächenbehandlungszusammensetzung
EP2852571A4 (de) Zusammensetzungen und verfahren zur behandlung von mukositis
EP2906580A4 (de) Behandlung von amyotropher lateralsklerose

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150203

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20151102

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 29/00 20060101ALI20151027BHEP

Ipc: A61K 31/02 20060101ALI20151027BHEP

Ipc: A61P 25/04 20060101ALI20151027BHEP

Ipc: C07C 25/08 20060101AFI20151027BHEP

Ipc: A61K 31/136 20060101ALI20151027BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160913